Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company

Hansen Medical (NASDAQ: HNSN ), a global leader in intravascular robotics, today announced that current Board member Chris Lowe has been appointed Interim Chief Executive Officer effective yesterday. Mr. Lowe succeeds Bruce J. Barclay, President and CEO since 2010. The Board of Directors has retained Russell Reynolds Associates to